If the haemoglobin level continues to increase, therapy should be interrupted until the hemoglobin level begins to decrease, at which point therapy should be restarted at a dose approximately 25% below the previously administered dose.
Siis tohib ravi uuesti alustada annuses, mis on umbes 25% väiksem eelnevalt manustatud annusest.